Physician communication regarding cost when prescribing asthma medication to children

Clinical Pediatrics

Volumn 48, Issue 5, 2009, Pages 493-498

  Patel, Minal R ^a   Coffman, Janet M ^b,c   Tseng, Chien Wen ^d,e   Clark, Noreen M ^a   Cabana, Michael D ^b,c,f  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF HAWAII   (United States)

^e PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Asthma; Communication barriers; Family medicine; Pediatrics; Physician "patient relations; Prescription cost

Indexed keywords

ANTIASTHMATIC AGENT;

ARTICLE; ASTHMA; CHILD CARE; COST BENEFIT ANALYSIS; DOCTOR PATIENT RELATION; DRUG COST; GENERAL PRACTITIONER; INTERPERSONAL COMMUNICATION; MEDICAL PRACTICE; PATIENT CARE; PEDIATRICIAN; PERCEPTION; PHYSICIAN ATTITUDE; PRESCRIPTION; QUESTIONNAIRE; SELF REPORT;

ANTI-ASTHMATIC AGENTS; ASTHMA; ATTITUDE OF HEALTH PERSONNEL; CHILD; COMMUNICATION; FEMALE; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; PRESCRIPTION FEES; SOCIOECONOMIC FACTORS;

EID: 65949114662     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922808330110     Document Type: Article

References (21)

1. Saul S. In sour economy, some scale back on medications. New York Times. October 22, 2008: A1.
2. Centers for Disease Control. Asthma and allergies (2007). http://www.cdc.gov/HealthyYouth/asthma/index.html. Accessed August 17, 2008.
3. National Heart, Lung, and Blood Institute. Expert Panel Report 2: Guidelines for the Management of Asthma (National Institutes of Health Publication No 97-4051). Bethesda, MD: National Heart, Lung, and Blood Institute ; 1997.
4. Piette JD, Heisler M., Wagner TH Cost-related medication underuse: do patients with chronic illnesses tell their doctors ? Arch Intern Med. 2004 ; 164: 1749-1755. (Pubitemid 39215643)
5. Bender BG, Rand C. Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol. 2004 ; 4: 191-195. (Pubitemid 38685520)
6. Fung V., Tager IB, Brand R., Newhouse JP, Hsu J. The impact of generic-only drug benefits on patients' use of inhaled corticosteroids in a Medicare population with asthma. BMC Health Serv Res. 2008 ; 8: 151-160.
7. Ungar WJ, Kozyrskyj A., Paterson M., Ahmad F. Effect of cost-sharing on use of asthma medication in children. Arch Pediatr Adolesc Med. 2008 ; 162: 104-110.
8. Alexander GC, Casalino LP, Tseng CW, McFadden D., Meltzer DO Barriers to patient-physician communication about out-of-pocket costs. J Gen Intern Med. 2004 ; 19: 856-860. (Pubitemid 39096358)
9. Reichert S., Simon T., Halm EA Physicians' attitudes about prescribing and knowledge of the costs of common medications. Arch Intern Med. 2000 ; 160: 2799-2803.
10. Shrank WH, Asch SM, Joseph GJ, et al. Physicians' perceived knowledge of and responsibility for managing patients' out-of-pocket costs for prescription drugs. Ann Pharmacother. 2006 ; 40: 1534-1540. (Pubitemid 44330197)
11. Pham HH, Alexander GC, O'Malley AS Physician consideration of patients' out-of-pocket costs in making common clinical decisions. Arch Intern Med. 2007 ; 167: 663-668. (Pubitemid 46598458)
12. Tseng CW, Tierney EF, Gerzoff RB, et al. Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research Into Action for Diabetes Study. Diabetes Care. 2008 ; 31: 261-266.
13. Cabana MD, Abu-Isa H., Thyne SM, Yawn B. Specialty differences in prescribing inhaled corticosteroids for children. Clin Pediatr(Phila). 2007 ; 46: 698-705. (Pubitemid 47366767)
14. Cabana MD, Rand CS, Becher OJ, Rubin HR Reasons for pediatrician nonadherence to asthma guidelines. Arch Pediatr Adolesc Med. 2001 ; 155: 1057-1062. (Pubitemid 32824052)
15. Cabana, MD, Ebel BE, Cooper-Patrick L., Powe NR, Rubin HR, Rand CS Barriers pediatricians face when using asthma practice guidelines. Arch Pediatr Adolesc Med. 2000 ; 154: 685-693. (Pubitemid 30437550)
16. Frankel LR On the Definition of Response Rates: A Special Report of the CASRO Task Force on Completion Rates. Port Jefferson, NY: Council of American Survey Research Organizations; 1982.
17. Tseng CW, Brook RH, Keeler E., Mangione CM Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients. JAMA. 2003 ; 290: 222-227. (Pubitemid 37430061)
18. Bender BG, Bender SE Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires. Immunol Allergy Clin North Am. 2005 ; 25: 107-130. (Pubitemid 39576680)
19. Tseng CW, Dudley RA, Brook RH, et al. Elderly patients' preferences and experiences with providers in managing their drug costs. J Am Geriatr Soc. 2007 ; 55: 1974-1980. (Pubitemid 350230953)
20. Alexander GC, Tseng CW Six strategies to identify and assist patients burdened by out-of-pocket prescription costs. Cleve Clin J Med. 2004 ; 71: 433-437. (Pubitemid 38821202)
21. Cummings SM, Savitz LA, Konrad TR Reported response rates to mailed physician questionnaires. Health Serv Res. 2001 ; 35: 1347-1355. (Pubitemid 32163983)